Exponent INC
Market Movers (8-K)
NASDAQ
EXPO
Exponent INCExponent, Inc. announced the results of its annual meeting of stockholders, including the election of directors, ratification of independent auditors, and advisory vote on executive compensation.
NASDAQ
EXPO
Exponent INCExponent, Inc. reported double-digit revenue and earnings growth for Q1 2026 while increasing its share repurchase authorization by $50 million.
NASDAQ
EXPO
Exponent INCExponent, Inc. has appointed John Pye as President and Eric Anderson as CFO, effective May 1, 2026, with significant leadership transitions including the retirement of Paul Johnston and the appointment of Karen Richardson as Chairman.
NASDAQ
EXPO
Exponent INCExponent, Inc. reported robust third-quarter financial results with double-digit revenue growth, declared a $0.30 quarterly dividend, and authorized an additional $100 million for share repurchases.
Better than expected
NASDAQ
EXPO
Exponent INCExponent, Inc. announced second quarter 2025 financial results with revenues flat but exceeding expectations, despite a decrease in net income and EBITDA, while declaring a quarterly cash dividend.
Better than expected
NASDAQ
EXPO
Exponent INCExponent, Inc. announced the successful election of all nominated directors, the ratification of KPMG as its independent auditor, and the advisory approval of executive compensation at its annual stockholders' meeting on June 5, 2025.
Quarterly Earnings (10-Q)
NASDAQ
EXPO
Exponent INCExponent, Inc. reported a 14% increase in Q1 2026 revenue to $166.3 million, driven by strong demand in consumer electronics and utility risk management.
NASDAQ
EXPO
Exponent INCExponent, Inc. announced an 8% increase in third-quarter revenues and a 10% rise in diluted earnings per share, alongside an additional $100 million share repurchase authorization.
NASDAQ
EXPO
Exponent INCExponent, Inc. reported a 9% decrease in net income for Q2 2025, driven by increased compensation expenses and lower billable hours, despite a slight revenue increase.
Worse than expected
NASDAQ
EXPO
Exponent INCExponent Inc. saw a marginal increase in revenue for Q1 2025, but experienced a decrease in net income due to higher operating expenses and changes in tax impacts.
Worse than expected
NASDAQ
EXPO
Exponent INC10-Q: Exponent Inc. Reports Slight Revenue Increase in Q3 2024, Driven by Consumer Electronics Sector
Exponent Inc. saw a modest revenue increase in the third quarter of 2024, with growth in the consumer electronics sector offsetting challenges in other areas.
NASDAQ
EXPO
Exponent INCExponent, Inc. saw a slight increase in revenue and a notable rise in net income during the second quarter of 2024, driven by demand for reactive services and effective resource management.
Better than expected
Annual Reports (10-K)
NASDAQ
EXPO
Exponent INCExponent, Inc. reported a 4.2% revenue increase to $582 million for fiscal year 2025, driven by dispute-related services, but saw net income decline by 2.7% to $106 million and diluted EPS decrease to $2.07.
Worse than expected
NASDAQ
EXPO
Exponent INCExponent Inc. has filed an amendment to its annual report on Form 10-K to correct a hyperlink for Exhibit 3.2(i).
NASDAQ
EXPO
Exponent INCExponent Inc. announces a rise in net income for fiscal year 2024, driven by effective resource management and increased demand for proactive services, despite a decrease in technical full-time equivalent employees.
Better than expected
NASDAQ
EXPO
Exponent INCExponent Inc. has filed an amendment to its annual report on Form 10-K to correct a hyperlink for an exhibit and update the date of the Annual Meeting of Stockholders.
NASDAQ
EXPO
Exponent INCExponent Inc.'s 2023 10-K filing reveals a revenue increase driven by demand in transportation and energy sectors, but a decrease in net income due to higher operating expenses.
Worse than expected
Insider Trading (Form 4)
NASDAQ
EXPO
Exponent INCCatherine Corrigan, Chief Executive Officer and a Director of Exponent Inc, reported multiple transactions in common stock on July 28, 2026.
NASDAQ
EXPO
Exponent INCForm 4: Exponent CEO Sells Shares
Catherine Corrigan, Chief Executive Officer and a Director of Exponent Inc, sold 1,737 shares of common stock on July 15, 2026 for $62.78 per share.
NASDAQ
EXPO
Exponent INCCatherine Corrigan, CEO and Director of Exponent Inc., acquired 7,872 shares of common stock on June 25, 2026, at a price of $25.405 per share.
NASDAQ
EXPO
Exponent INCExponent CEO Catherine Corrigan exercised stock options and sold shares to cover tax obligations and exercise costs.
NASDAQ
EXPO
Exponent INCDirector Carol Lindstrom converted vested restricted stock units into common stock and received a new grant of restricted stock units.
NASDAQ
EXPO
Exponent INCDirector George H. Brown converted vested restricted stock units into common stock and received a new grant of 2,859 units.
Proxy Statements (Def-14A)
NASDAQ
EXPO
Exponent INCExponent, Inc. announces its 2026 Annual Meeting of Stockholders, featuring key leadership transitions and executive compensation approvals.
NASDAQ
EXPO
Exponent INCExponent, Inc. will hold its 2025 Annual Meeting of Stockholders virtually on June 5, 2025, to elect directors, ratify the appointment of KPMG LLP, and approve executive compensation.
NASDAQ
EXPO
Exponent INCExponent, Inc. will hold its 2024 Annual Meeting of Stockholders virtually on June 6, 2024, and has made proxy materials available online.
NASDAQ
EXPO
Exponent INCExponent, Inc. is holding its annual meeting of stockholders on June 6, 2024, to vote on the election of directors, ratification of the auditor, executive compensation, and an amendment to the equity incentive plan.
Schedule 13G - Passive Investments
NASDAQ
EXPO
Exponent INCKayne Anderson Rudnick Investment Management, LLC has increased its beneficial ownership in Exponent Inc. to 7.9% as of March 31, 2026.
NASDAQ
EXPO
Exponent INCVanguard Capital Management has filed a Schedule 13G reporting a 5.25% beneficial ownership stake in Exponent Inc.
NASDAQ
EXPO
Exponent INCVanguard Portfolio Management has reported beneficial ownership of 2,990,195 shares, representing 6.07% of Exponent Inc.'s common stock as of March 31, 2026.
NASDAQ
EXPO
Exponent INCThe Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Exponent Inc following an internal realignment.
NASDAQ
EXPO
Exponent INCConestoga Capital Advisors reported a 5.06% beneficial ownership stake in Exponent Inc. common stock as of December 31, 2025, filed as an amendment to its Schedule 13G.
NASDAQ
EXPO
Exponent INCConestoga Capital Advisors has filed an amended Schedule 13G, reporting a passive beneficial ownership of 5.87% in Exponent Inc. as of December 31, 2024.